Viewing Study NCT00079404

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2026-01-02 @ 11:15 AM
Study NCT ID: NCT00079404
Status: COMPLETED
Last Update Posted: 2013-06-05
First Post: 2004-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Undifferentiated Leukemia View
None Recurrent Childhood Acute Lymphoblastic Leukemia View
None Recurrent Childhood Acute Myeloid Leukemia View
None Secondary Acute Myeloid Leukemia View
None Unspecified Childhood Solid Tumor, Protocol Specific View
Keywords: